Aradhye Shreeram 4
4 · Dicerna Pharmaceuticals Inc · Filed Oct 2, 2020
Insider Transaction Report
Form 4
Aradhye Shreeram
EVP & Chief Medical Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2020-10-01+124,700→ 124,700 totalExercise: $18.69Exp: 2030-09-30→ Common Stock (124,700 underlying) - Award
Restricted Stock Units
2020-10-01+28,100→ 28,100 total→ Common Stock (28,100 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs") that vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of September 15, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer through the applicable vesting date. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock.
- [F2]The option vests 25% on the first year anniversary of the vesting start date of September 8, 2020 and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject in each case to the Reporting Person's continued employment or service with the Issuer through the applicable vesting date.